Composition and methods for the treatment of myopia
US12102628B2 · kind B2 · utility
0Cited by
8References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2022 |
| Grant date | Oct 1, 2024 |
| Priority date | — |
| Expiry date | Mar 28, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods useful in slowing, inhibiting, or regressing the progression of myopia, while minimizing pupil dilation and light sensitivity are provided herein. Provided compositions can include a muscarinic receptor antagonist and a miotic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.